Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 40,100
+400 (1.01%)
At close: Oct 30, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 585.46 billion as of October 29, 2026. It is the 15,341st most valuable company in the world and the 407th biggest in South Korea. Its market cap has decreased by 53.80% in one year.
Market Cap
585.46B
Enterprise Value
116.44B
Revenue
293.03B
Global Rank
Country Rank
#407 South Korea
PE Ratio
6.24
ChartMarket Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 585.46B, a decrease of -67.10%. That is a compound annual growth rate of -64.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 585.46B | -41.80% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.16T |
| Celltrion | 43.24T |
| ALTEOGEN | 15.32T |
| Samsung Epis Holdings | 7.62T |
| Chabiotech | 625.32B |
| InBody Co.,Ltd | 609.94B |
| Proteina | 594.80B |
| Pharmicell | 588.04B |